deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT04400994

IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus

The Use of IVIG in Combination With Rituximab VS Rituximab as the First Line Treatment of Pemphigus

Sponsor: The University of Hong Kong

Conditions Pemphigus
Interventions IVIg Rituximab
Updated 17 times since 2020 Last updated: Jul 2, 2025 Started: Jun 20, 2020 Primary completion: Dec 31, 2025 Completion: Jun 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Pemphigus and is currently ongoing. The University of Hong Kong leads this study, which shows 17 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Sep 2020 · 2 months · monthly snapshot~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Jun 2021 · 3 months · monthly snapshot~Jun 2021 – ~Jun 2022 · 12 months · monthly snapshot~Jun 2022 – ~Sep 2022 · 3 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Sep 2023 · 10 months · monthly snapshot~Sep 2023 – ~Nov 2023 · 2 months · monthly snapshot~Nov 2023 – ~Apr 2024 · 5 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshot~Aug 2025 – present · 11 months · monthly snapshot

Change History

17 versions recorded

  1. Aug 2025 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Sep 2024 — Aug 2025 [monthly]

    Active Not Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Apr 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Nov 2023 — Apr 2024 [monthly]

    Active Not Recruiting PHASE2

▶ Show 12 earlier versions

  1. Sep 2023 — Nov 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Nov 2022 — Sep 2023 [monthly]

    Recruiting PHASE2

  3. Sep 2022 — Nov 2022 [monthly]

    Recruiting PHASE2

  4. Jun 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  5. Jun 2021 — Jun 2022 [monthly]

    Recruiting PHASE2

  6. Mar 2021 — Jun 2021 [monthly]

    Recruiting PHASE2

  7. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  8. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  9. Nov 2020 — Dec 2020 [monthly]

    Recruiting PHASE2

  10. Sep 2020 — Nov 2020 [monthly]

    Recruiting PHASE2

  11. Jul 2020 — Sep 2020 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  12. Jun 2020 — Jul 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The University of Hong Kong
Data source: The University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations